Veterinary Antihistamines Market Revenue to Attain USD 2.01 Bn by 2033

21 Jul 2025

Share :

Table of Content

1. Veterinary Antihistamines Market Revenue and Trends 2025 to 2033 2. Key Factors Responsible for the Growth of the Veterinary Antihistamines Market 3. Segment Insights 4. Regional Insights 5. Veterinary Antihistamines Market Coverage 6. Veterinary Antihistamines Market Key Players

Veterinary Antihistamines Market Revenue and Trends 2025 to 2033

The global veterinary antihistamines market revenue is valued at USD 1.32 billion in 2025 and is expected to attain around USD 2.01 billion by 2033, growing at a CAGR of 5.43% during forecast period. With the increasing number of cases of allergic conditions among animals, the demand for veterinary antihistamines is rising, which is propelling the growth of the market. Veterinary antihistamines are the first-line, fast-acting, and most convenient solutions for managing allergy cases in pets, as they are available in multiple dosage forms and are over-the-counter.

Key Factors Responsible for the Growth of the Veterinary Antihistamines Market

The veterinary antihistamines market is primarily driven by the increasing cases of allergic conditions in companion animals, such as dermatitis, insect bite reactions, and food allergies. The demand for veterinary care and allergy management is fueled by the growth in pet ownership, particularly in urban areas. Parental awareness of animal health and wellness encourages the early identification and treatment of allergic symptoms in pets. Furthermore, veterinary formulations are advancing technologically, and over-the-counter (OTC) antihistamines are becoming more accessible. The escalating costs of veterinary healthcare and the expansion of veterinary clinics and hospitals globally continue to propel the market.

Segment Insights

• By drug type, the H1 receptor antagonists (H1 blockers) segment dominated the market in 2024, as it is the most preferred treatment option for allergic reactions, pruritus, and inflammatory conditions in animals.
• By dosage form, the tablets & capsules segment held the largest share of the market in 2024 because pets are more likely to abide by their owner's prescriptions due to consistent dosing, accurate dosing, and ease of administration.
• By animal type, the dogs segment captured the largest share of the market in 2024 due to the increased instances of dogs experiencing allergies. The increased rates of dog ownership further bolstered the segmental growth.
• By distribution channel, the veterinary clinics & hospitals segment led the market as they provide professional diagnosis and trusted prescriptions. Their capability to immediately provide effective treatments for animals with allergies makes them the primary point of care for pet owners, bolstering segmental growth.

Regional Insights

North America held the largest share of the veterinary antihistamines market with the largest share in 2024. This is mainly due to high ownership of pets, established veterinary services, and heightened awareness of allergies among pet parents. Meanwhile, the market in Asia Pacific is expected to grow at a rapid pace due to the increasing accessibility to advanced veterinary services, rising spending on animal healthcare, and the expansion of veterinary clinics in countries like India, China, and Australia.

Veterinary Antihistamines Market Coverage

Recent Development

• In June 2024, the FDA approved Trimeprazine with Prednisolone tablets as an antipruritic and antitussive for dogs with itch and cough conditions. This antihistamine and corticosteroid reduce the inflammation commonly associated with most skin disorders of dogs.
  (Source: https://www.avma.org)

Veterinary Antihistamines Market Key Players

• Zoetis Inc.
• Boehringer Ingelheim Animal Health
• Elanco Animal Health
• Merck Animal Health
• Virbac
• Dechra Pharmaceuticals
• Vetoquinol
• Ceva Santé Animale
• Bayer Animal Health (now part of Elanco)
• Norbrook Laboratories
• Bimeda
• Neogen Corporation
• Phibro Animal Health
• Vétoquinol
• Ourofino Saúde Animal
• Kyoritsu Seiyaku Corporation
• Med-Pharmex
• KRKA Pharmaceuticals
• Chanelle Pharma
• PetIQ Inc.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6430

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.co |+1 804 441 9344